Scintimammography, or single gamma nuclear imaging of the breast, has shown promise as a way of characterizing certain biological properties of suspicious breast masses.
Introduction
Routine screening using x-ray mammography is currently the most sensitive method for the early detection of breast cancer. However, even if suspicious masses are detected, determination of the benign or malignant nature of a mass is often impossible from the x-ray image, which contains no functional information that could aid in characterizing the mass as either cancerous or benign. The result is that between 65% and 85% of excisional and core needle breast biopsies performed based on mammographic findings alone are unnecessary (1, 2).
One promising approach to functional breast imaging is scintimammography, or breast scintigraphy (3, 4) . In scintimammography, a radiolabeled pharmaceutical that is taken up preferentially by malignant lesions is injected intravenously. Gamma cameras then image the spatial distribution of the gamma rays exiting the breast and compare the activity in the suspicious mass with that of the surrounding healthy tissue. At the University of Virginia (UVa), we are developing a dual modality breast imaging system that combines high resolution digital x-ray (structural) and gamma ray (functional) detectors integrated on a single system. Because the x-ray transmission and gamma emission images are obtained with the breast held in a fixed, common position, the fused images are precisely superimposed so that the structural and functional information can be correlated. It is anticipated that such an approach may help avoid unnecessary biopsies, identify potential tumors that may be obscured on a typical mammogram, and aid in monitoring for possible recurrence of cancer following treatment.
Materials and Methods
The digital x-ray and gamma ray detectors are mounted on a conventional upright mammographic unit (Lorad M-III). The digital mammography detector consists of six butted modules arranged in a 2 x 3 array. Each module contains a 2k x 2k CCD bonded to the small end of a 3.3:1 fiber optic taper. The large ends of the six tapers are optically coupled to a common 20 cm x 30 cm Gd 2 O 2 S:Tb phosphor. The taper sides are square and polished to achieve intra-module gaps of less than 0.030 mm. The pixel size is 0.046 microns, and a full digital mammogram contains 4224 x 6264 pixels, with 16 bits of inten-sity resolution per pixel. The inactive border at the patient's chest wall is 7 mm wide, only slightly more than that of current screen-film mammography systems. Performance of the detector in terms of the spatial frequency dependent detective quantum efficiency has been published elsewhere (5).
The dedicated gamma camera of the dual modality breast imaging system consists of 16 tiled position sensitive photomultiplier tubes (PSPMTs), arranged in a 4 x 4 array. The PSPMT array is optically coupled via acrylic light guides to a 30 x 30 array of NaI(Tl) crystals. Each crystal is 3.0 mm square and 6 mm thick, and the crystal center-to-center spacing is 3.3 mm. Because of the compact design of the PSPMTs and camera housing, the gamma camera is able to image to within 8.0 mm of the patient's chest wall, a performance comparable to that of x-ray mammography and far superior to that of clinical gamma cameras (tens of cm). The camera uses a high resolution etched tungsten collimator with square apertures. The intrinsic detector spatial resolution is 3.2 mm FWHM, and the camera sensitivity is 300 cpm/mCi.
Image Acquisition
In a typical dual modality study, the patient is first positioned in a manner similar to that used in conventional mammography, except with substantially reduced breast compression. With the gamma camera pivoted out of the path of the x-ray beam (see Figure 1 ), a digital mammogram is obtained, and the image appearing on the acquisition monitor is used to verify that the portion of the breast containing the suspicious lesion is approximately centered in the field of view. Next, the gamma camera is swung back into position above the breast and is lowered via a linear translation stage to a position just above the compression paddle (see Figure  2 ). Following acquisition of the gamma emission image (~10 minute acquisition time), the x-ray and gamma ray images are corrected for translational and rotational offsets and their pixel sizes are re-scaled to a common value using a stored co-registration file. x-ray and gamma ray images are separately intensity scaled for optimal display of the area of the lesion, then the common areas of each are fused into a single dual modality image.
Results and Discussion
The dual modality breast imaging system is now undergoing a small scale clinical evaluation at UVa's Diagnostic Center for Women, to evaluate its diagnostic accuracy in differentiating benign and malignant breast masses.
Volunteers who are scheduled to undergo breast biopsy are eligible to participate, and are scanned prior to biopsy. To date, 10 studies have been performed. Table I compares our results with those of the pathology reports. Although this is a small sample size, the exceptional results so far (100% accuracy in 9 of 10, with one indeterminate) are promising. An example study is shown in Figure 3 .
Prior to the development of the dual modality system, our group gained extensive experience with prone scintimammography. Using a specially designed imaging table and dedicated small field of view gamma cameras, we were able to obtain views that are inaccessible to large conventional cameras, such as the caudio-cranal view (6). In spite of this, we found that correlation between the x-ray mammography and scintimammography images was often difficult. The primary sources of ambiguity were the difference in breast configuration between the two studies (compressed for mammography vs. not compressed and pendulant for scintimammography) and the lack of physical landmarks in the scintimammographic image (often the breast filled the entire field of view, so that even the skin line was not visible). The high degree of correlation between areas of the x-ray and gamma ray images obtained on the dual modality breast imaging system has essentially eliminated this ambiguity. Unambiguous registration between the two images has proven especially useful in situations where more than a single region of focal uptake was observed on the gamma image.
In addition to improving correlation of findings on mammography with those on scintigraphy, the dual modality has also improved the quality of the scintimammography exam relative to our earlier prone imaging approach, by the use of mild compression of the breast (6, 7). Compression improves lesion contrast by reducing the path length of intervening breast tissue between the lesion and collimator, thus decreasing attenuation of gamma rays emitted from the lesion. The images demonstrate that lesions very close to the chest wall can be visualized with the dual modality system. The pathology report indicated infiltrating ductal carcinoma and ductal carcinoma in situ. 
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